Last reviewed · How we verify
NCT05178186: THYCOVID
Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer
NA trial testing Thyroidectomy in Thyroid Carcinoma in 22,974 participants. Completed in 15 September 2022.
31 July 2022
Quick facts
| Lead sponsor | University of Cagliari |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 22,974 |
| Start date | 20 June 2022 |
| Primary completion | 31 July 2022 |
| Estimated completion | 15 September 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Thyroidectomy
Conditions studied
- Thyroid Carcinoma — all drugs for Thyroid Carcinoma →
Sponsor
University of Cagliari
Who can join
18 and older, any sex, with Thyroid Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The impact of the COVID-19 pandemic has heavily influenced routine medical care. In the first months of the pandemic, healthcare authorities restricted medical care to emergency procedures, postponing elective surgical activity. Conversely, screening programmes and planned examinations have been temporarily suspended or delayed. Gradually, elective surgery and clinical activities have resumed, thanks to the weakening of the pandemic, to a better organization of the healthcare systems and to the diffusion of COVID-19 vaccines. In the present study, we aim to evaluate the impact of the COVID-19 pandemic on surgery for thyroid carcinoma. Particularly, we aim to investigate whether the delay in operations, screening programmes, and planned examinations for patients under follow-up after thyroid surgery have led to an increased number of aggressive tumours. To evaluate this aspect, we aim to compare the patients who had undergone thyroidectomy for thyroid cancer before the COVID-19 pandemic (from February 2019 to February 2020), during the first phase of the pandemic (from March 2020 to September 2020), and after the first phase of the COVID-19 pandemic (from October 2020 to October 2021).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
Medas F, Dobrinja C, Al-Suhaimi EA, Altmeier J, et al · · 2023 · cited 17× · PMID 37127041 · DOI 10.1016/s2213-8587(23)00094-3
Verify or expand the search:
- PubMed search for NCT05178186
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Thyroidectomy
Trials testing the same drug.
- NCT07274891 — LigaSure vs Bipolar Diathermy in Thyroidectomy · NA · not yet recruiting
- NCT05851404 — Management of Indeterminate Thyroid Nodules Across Different World Regions · unknown
- NCT05699304 — Complications After Thyroid Surgeries: 10 Years' Experience · completed
- NCT05033626 — Simultaneous Operations on the Thyroid Gland and Hyoid Suspension in Patients With Combined Thyroid Pathology and OSA · NA · unknown
- NCT04904159 — Scoring System for Thyroid Gland Pathologies · unknown
Other recruiting trials for Thyroid Carcinoma
Currently open trials in the same condition.
- NCT07218315 — Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma · NA · recruiting
- NCT07359586 — Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia · recruiting
- NCT07473518 — Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy · recruiting
- NCT07072143 — An International Study on Pediatric Patients With Rare Tumors. · recruiting
- NCT06146764 — CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma · recruiting
Other University of Cagliari trials
Trials by the same sponsor.
- NCT06872151 — Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Per · Phase 4 · completed
- NCT06523920 — Protecting Autologous Free Flaps From Ischemia/Reperfusion Damage With Cold Storage. · NA · not yet recruiting
- NCT06484205 — Evaluation of the Effectiveness of the World Health Organization QualityRights Training in Italy · NA · recruiting
- NCT06526962 — 5Fr Bipolar Electrode vs. Conical Optical 5Fr Fibers for Dual Wave-length Diode Laser for Hysteroscopic Polypectomy · recruiting
- NCT06579378 — Feasibility Study of Virtual Sail 3D in Cognitive Functions · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05178186 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cagliari
- Last refreshed: 15 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05178186.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing